drugset
Drugs / TK-112690
last change Sep 2023 re-read 3 minutes ago

TK-112690

also known as O2,2'-anhydro-5-methyluridine

Small molecule

Developed for
mucositis
Investigated by
Tosk, Inc. · Crystal Life Sciences · SIRO Clinpharm Private Limited · SIRO Clinpharm Pvt. Ltd.

Trials 3

today NCT05658016 · Ph 2 NCT05669521 · Ph 2 NCT04046250 · Ph 2
2020202120222023202420252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT05658016 Jun 2022 → Sep 2023 mucositis Tosk, Inc. Unknown No outcome recorded
Phase 2 NCT05669521 Jun 2022 → Sep 2023 mucositis Tosk, Inc. Unknown No outcome recorded
Phase 2 NCT04046250 May → Oct 2019 mucositis Tosk, Inc. Completed No outcome recorded

Evidence & citations 3 cited values

Every value below carries the sentence it was read from. 4 sources stand behind the page.

FieldValueCited text
Known as TK112690 “TK112690 treatment Post 5-FU chemotherapy” NCT05669521 ↗
3

NCT05669521 ↗

NCT04046250 ↗

NCT05658016 ↗
Known as O2,2'-anhydro-5-methyluridine ChEMBL registry synonym — accepted as the source's own label CHEMBL3251296 ↗
Modality Small molecule — CHEMBL3251296 ↗